Condition 1: Hysterectomy. Condition 2: Blood transfusion. Condition 3: Tranexamic acid. Acquired absence of both cervix and uterus
Conditions
Interventions
Intervention 1: Intervention group: recieve 1 gr tranexamic acid as slow intravenus bolus.Tranexamic injection was prepared by diluting 1 gr (10ml) tranexamic acid with 20 ml of5% glucose. Interventio
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
35 Years to 70 Years
Inclusion criteria
Inclusion criteria: Candidate of vaginal or abdominal hystrectomy Between 35-70 years old American society of anesthesiologist (ASA) grade for physical status 1 or 2
Exclusion criteria
Exclusion criteria: Anemia Hepatic dysfunction Renal dysfunction Serious cardiac disease Serious respiratory disease Acquired or congenital coagulopathy Previous history of deep venus thrombosis or thromboembolic disease ASA more than 2 Sensitive to tranexamicacid
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood loss. Timepoint: During and after sugery. Method of measurement: During the surgery by weighting swabs,spinges,operative drapes and measuring the volume in suction buttles after surgery by measuring the drain collectors in post anesthesia care unit.;Blood transfusion. Timepoint: During and 12 hours after surgery. Method of measurement: Pack cell. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemoglobin. Timepoint: During and 12 hours after surgery. Method of measurement: Blood test.;Hematocrit. Timepoint: Before and 12 hours after surgery. Method of measurement: Blood test.;Operation time. Timepoint: Operation time. Method of measurement: Timer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactEnsiyeh Bahadoran
Qazvin University of Medical Sciences
Outcome results
None listed